Leticia T. Moreno

A Polymorphism in the Cytidine Deaminase Promoter Predicts Severe Capecitabine-Induced Hand-Foot Syndrome

J. Benítez, A. González-Neira, G. Pita, 2011, Clinical Cancer Research.

Severe Capecitabine-Induced Hand-Foot Syndrome Promoter Predicts Cytidine Deaminase

J. Benítez, G. Pita, M. Alonso, 2011 .

Whole Exome Sequencing Suggests Much of Non-BRCA1/BRCA2 Familial Breast Cancer Is Due to Moderate and Low Penetrance Susceptibility Alleles

J. Benítez, M. Southey, F. Odefrey, 2013, PloS one.

Pharmacogenetic variants and response to neoadjuvant single-agent doxorubicin or docetaxel: a study in locally advanced breast cancer patients participating in the NCT00123929 phase 2 randomized trial

J. Benítez, A. González-Neira, G. Pita, 2018, Pharmacogenetics and genomics.

DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Olufunmilayo I. Olopade, Mads Thomassen, Torben A. Kruse, 2014, PLoS genetics.

Exome sequencing of three cases of familial exceptional longevity

L. Rodríguez-Mañas, A. González-Neira, G. Pita, 2014, Aging cell.

Regulatory CDH4 Genetic Variants Associate With Risk to Develop Capecitabine‐Induced Hand‐Foot Syndrome

J. Benítez, R. Milne, A. González-Neira, 2020, Clinical pharmacology and therapeutics.

DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

A. Whittemore, D. Steinemann, F. Couch, 2014, PLoS genetics.